首页> 外文期刊>Molecular cancer research: MCR >Development of New EBV-Based Vectors for Stable Expression of Small Interfering RNA to Mimick Human Syndromes: Application to NER Gene Silencing.
【24h】

Development of New EBV-Based Vectors for Stable Expression of Small Interfering RNA to Mimick Human Syndromes: Application to NER Gene Silencing.

机译:稳定表达小干扰RNA模仿人类综合征的新的基于EBV的载体的开发:在NER基因沉默中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

We developed and characterized replicative small interfering RNA (siRNA) vectors for efficient, specific, and long-term gene silencing in human cells. We created stable XPA(KD) and XPC(KD) (knockdown) syngeneic cell lines to mimic human cancer-prone syndromes. We also silenced (HSA)KIN17. Several clones displaying undetectable protein levels of XPA, XPC, or (HSA)kin17 were grown for more than 300 days. This stability of gene silencing over several months of culture allows us to assess the specific involvement of these proteins in UVC sensitivity in syngeneic cells. Unlike XPA, (HSA)KIN17, and XPC gene silencing dramatically impeded HeLa cell growth for several weeks after transfection. As expected, XPA(KD) and XPC(KD) HeLa cells were highly UVC sensitive. They presented an impaired unscheduled DNA synthesis after UVC irradiation. Interestingly, XPC(KD) HeLa clones were more sensitive to UVC than their XPA(KD) or KIN17(KD) counterparts. Hygromycin B withdrawal led to the total disappearance of EBV vectors and the resumption of normal XPA or XPC protein levels. Whereas reverted XPA(KD) cells recovered a normal UVC sensitivity, XPC(KD) cells remained highly sensitive, suggestive of irreversible damage following long-term XPC silencing. Our results show that in HeLa cells, (HSA)kin17 participates indirectly in early events following UVC irradiation, and XPC deficiency strongly affects cell physiology and contributes to UVC sensitivity to a greater extent than does XPA. EBV-based siRNA vectors improve the interest of siRNA by permitting long-term gene silencing without the safety concerns inherent in viral-based siRNA vehicles.
机译:我们开发并表征了可复制的小干扰RNA(siRNA)载体,可在人类细胞中进行有效,特异性和长期的基因沉默。我们创建了稳定的XPA(KD)和XPC(KD)(组合式)同系细胞系,以模拟人类癌症多发综合征。我们还沉默了(HSA)KIN17。表现出无法检测到的XPA,XPC或(HSA)kin17蛋白水平的几个克隆生长了300天以上。在几个月的培养中,基因沉默的稳定性使我们能够评估这些蛋白质在同系细胞中对UVC敏感性的特异性参与。与XPA不同,(HSA)KIN17和XPC基因沉默在转染后数周内显着阻碍了HeLa细胞的生长。不出所料,XPA(KD)和XPC(KD)HeLa细胞对UVC高度敏感。他们提出了紫外线照射后受损的非计划DNA合成。有趣的是,XPC(KD)HeLa克隆比XPA(KD)或KIN17(KD)对UVC更敏感。潮霉素B的撤回导致EBV载体的完全消失和正常XPA或XPC蛋白水平的恢复。还原的XPA(KD)细胞恢复了正常的UVC敏感性,而XPC(KD)细胞保持高度敏感性,表明长期XPC沉默后不可逆转的损伤。我们的结果表明,在HeLa细胞中,(HSA)kin17间接参与UVC辐射后的早期事件,而XPC缺乏对XPC的影响极大地影响细胞生理,并且对UVC的敏感性更大。基于EBV的siRNA载体通过允许长期的基因沉默而无需担心基于病毒的siRNA载体固有的安全性,从而提高了siRNA的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号